Guangdong aims to develop a biopharmaceutical and healthcare industry cluster with a combined output value of more than 1 trillion yuan ($140.82 billion) in 2027. The plan outlines 38 tasks and measures to achieve this goal, focusing on innovation, product upgrading, industry clustering, and building an industry-friendly environment.
